Endothelial dysfunction: the common consequence in diabetes and hypertension.

Institute of Vascular Medicine, Li Ka Shing Institute of Health Sciences, and School of Biomedical Sciences, Chinese University of Hong Kong, Shatin, NT, Hong Kong SAR, China.
Journal of cardiovascular pharmacology (Impact Factor: 2.11). 04/2010; 55(4):300-7. DOI: 10.1097/FJC.0b013e3181d7671c
Source: PubMed

ABSTRACT Endothelial dysfunction plays a key role in the initiation of cellular events evolving into the development of vascular complications in diabetes and hypertension. Diminished production and function of endothelium-derived nitric oxide and other vasoprotective factors and/or the exaggerated production of proinflammatory and vasoconstrictors such as angiotensin II, endothelin-1, reactive oxygen species, and cyclooxygenase-derived metabolites of arachidonic acid eventually lead to endothelial dysfunction, resulting in elevated vascular tone which contributes to hypertension, vascular, and cardiac remodeling, culminating in microvascular, macrovascular, and renal damages. Specific therapies targeting reactive oxygen species using antioxidants and inhibitors of the rennin-angiotensin system or increasing endothelial nitric oxide synthase activity might assist to reverse endothelial dysfunction and thus reduce the related cardiovascular morbidity and mortality in diabetes and hypertension.

  • [Show abstract] [Hide abstract]
    ABSTRACT: One of the serious outcomes of diabetes mellitus is nephropathy. Measurement of microalbuminuria is a routine clinical practice for screening the diabetic nephropathy, but the injury to the kidney may be happening even without microalbuminuria. The association between urinary enzyme activities of N-acetyl-β-D-glucosaminidase (NAG) and angiotensin converting enzyme (ACE) and urine microalbumin was assessed in this study to define the possible biofactor for detection of early diabetic nephropathy. Urinary enzyme activities of NAG and ACE and urine microalbumin of 24 h, serum ACE, and some other clinical features are investigated in 35 type 2 diabetic patients. Glycated hemoglobin (HbA1c), triglycerides, serum ACE, and urine NAG were significantly elevated in diabetic groups compared to the healthy controls. There was no relation between urine NAG and microalbuminuria except in the group of diabetic patients which had urine NAG activity upper than 25 IU/ml; there was a correlation between urine NAG and serum ACE. We may conclude that before the finding of microalbumin in urine, the elevated urine NAG, as an early indicator of renal damage, is associated with serum ACE which is related to kidney vascular microangiopathies.
    International Journal of Diabetes in Developing Countries 01/2015; DOI:10.1007/s13410-015-0325-0 · 0.37 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The receptor of advanced glycation end products (RAGE) is a cell-surface receptor that is a key factor in the pathogenesis of diabetic complications, including vascular disorders. Dysfunction of the actin cytoskeleton contributes to disruption of cell-membrane repair in response to various type of endothelial cell damage. However, the underlying mechanism by RAGE involved in the remodeling of actin cytoskeleton, which globular actin (G-actin) form to filamentous actin (F-actin) still remains unclear. In this study we examined the role of thymosin beta 4 (Tβ4) – which binds to actin, blocks actin polymerization, and maintains the dynamic equilibrium between G-actin and F-actin in human umbilical vein endothelial cells (HUVECs) – in the response to RAGE. Tβ4 increased cell viability and decreased the levels of reactive oxygen species in HUVECs incubated with advanced glycation end products (AGEs). Tβ4 reduced the expression of RAGE, consistent with a down-regulation of the F-actin to G-actin ratio. The effect of remodeling of the actin cytoskeleton on RAGE expression was clarified by adding phalloidin, which stabilizes F-actin. Moreover, small interfering RNA was used to determine whether intrinsic Tβ4 regulates RAGE expression in the actin cytoskeleton. The absence of intrinsic Tβ4 in HUVECs evoked actin cytoskeleton disorder as well as increased RAGE expression. These findings suggest that regulation of the actin cytoskeleton by Tβ4 plays a pivotal role in the RAGE response to AGEs.This article is protected by copyright. All rights reserved
    The Journal of Physiology 01/2015; 593(8). DOI:10.1113/jphysiol.2014.287045 · 4.54 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Panax ginseng is commonly used to treat cardiovascular complications in oriental countries. This study investigated mechanisms underlying vascular benefits of ginsenoside Rb3 (Rb3) in hypertension. Renal arteries were prepared from spontaneously hypertensive rats (SHR) and normotensive WKY rats. Most arterial rings were ex vivo cultured for 8 hours. Rings were suspended on myograph for reactivity assay. The expression of NADPH oxidases were assessed by Western blotting and immunohistochemistry. The amount of reactive oxygen species (ROS) was measured using dihydroethidium fluorescence imaging and production of nitric oxide (NO) was determined using fluorescent NO indicator DAF-FM diacetate in human endothelial cells. Ex vivo 8-hour treatment with Rb3 concentration-dependently augmented endothelium-dependent relaxations, suppressed endothelium-dependent contractions, and reduced ROS production and expressions of NOX-2, NOX-4 and p67(phox) in renal arteries from SHR and Rb3 treatment also normalized angiotensin II (Ang II)-stimulated elevation in ROS and expression of NOX-2 and NOX-4 in renal arteries from WKY rats. Rb3 inhibited Ang II-induced reduction of NO production and phosphorylation of eNOS in human endothelial cells. In addition, the beneficial effects of Rb3 to inhibit oxidative stress were observed in renal arteries from hypertensive patients or in Ang II-treated arteries from normotensive subjects. Ex vivo Rb3 treatment restores the impaired endothelial function in hypertension through reversing the over-expression of NADPH oxidases and subsequent ROS overproduction, leading to improved NO bioavailability. The present novel findings suggest that Rb3-containing medicinal plants might be effective in curtailing oxidative stress and protecting endothelial function in hypertension.
    British Journal of Pharmacology 02/2014; 171(13). DOI:10.1111/bph.12660 · 4.99 Impact Factor